Smartphones Could Monitor Parkinson's Effect on Life

Article

Researchers were able to pull 25,000 hours of monitoring data.

Sensor data from smartphones have been found to be capable of providing once inaccessible insides into the daily behavior and motor functioning of Parkinson’s disease (PD) patients, according to a study presented Tuesday, June 5 at the 21st International Congress of Parkinson’s Disease and Movement Disorders in Vancouver, BC.

The possibility of smartphone-based assessments and sensors that could enable remote, passive monitoring of gait and mobility in early stages of PD was investigated by a team of researchers based in Basel, Switzerland.

A clinical trial studied 44 PD patients carrying smart phones on their person for 24 weeks in a home-based setting. The phones, being carried in patients’ pockets or waist packs throughout the day, measured continuous movement and location.

Researchers then categorized data into different types of routine human activities, then compared to the study’s clinical data. Comparisons included the MDS Unified Parkinson’s Disease Rating Scale (MDS-UPDRS).

The trial managed to compile over 25,000 hours of passive monitoring data, and the measured mobility patterns correlated with disease severity, as measured by clinical gold standards.

Alberto Espay, associate professor of Neurology at the University of Cincinnati, said that if even the preliminary evidence only suggests that smartphones could be an untapped source of additional PD patient mobility data, the presented abstract is of interest.

“This is also important because of what is referred to as the ecologically valid setting in which the data are collected, outside of a clinic or movement laboratory.” Espay said.

Espay expressed caution for passive data collection, noting algorithms used for collection will need to be able to distinguish different types of movement — such as deliberate movement, peak-dose dyskinesia, or diphasic dyskinesia for movement disorder patients.

The algorithms will also have to distinguish different types of rest, from acts as simple as sitting and reading, to sleeping, Espay said.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.